Dilsu Dicle Erkan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dilsu Dicle Erkan has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Naz Güleray Lafcı
Department of Medical Genetics, Faculty of Medicine, Hacettepe University, Ankara, Turkey
3 shared publications - Ceren Damla Durmaz
Department of Medical Genetics, School of Medicine, Hacettepe University, Ankara, Turkey
2 shared publications - Ulas Can Kolac
Department of Orthopedics and Traumatology, Hacettepe University, Ankara, Türkiye
2 shared publications - Ömer Çağrı Akçin
Department of Medical Genetics, Faculty of Medicine, Hacettepe University, Ankara, Turkey
2 shared publications - Abdurrahman Ayaz
Istanbul Medeniyet University, Faculty of Medicine
1 shared publication Ali Varan
Division of Pediatric Oncology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey
1 shared publication
Latest Publications
- 28 October 2026
- Published by Bioscientifica in Journal of Molecular Endocrinology
- Vol. 77 (4)
Molecular resolution of a TNXA / TNXB CH-1 chimera and the non-chimeric TNXB allele in CAH-X
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency can co-occur with CAH-X syndrome, a connective tissue disorder caused by TNXB haploinsufficiency, resulting from TNXA/TNXB chimeric genes within the RCCX module. Here, we performed a family-based molecular investigation to define a complex RCCX rearrangement, confirm the TNXA/TNXB chimera architecture, and independently assess the non-chimeric TNXB allele in a phenotypically discordant father–daughter pair. The proband underwent targeted CYP21A2 variant screening, trio gene-specific CYP21A2 sequencing, and copy-number analysis by multiplex ligation-dependent probe amplification. TNXA/TNXB short-read data were examined at pseudogene-informative positions, and the rearranged allele was characterized by RCCX-spanning long-range PCR using CYP779F and Tena32F followed by sequencing. A separate 2,536 bp allele-specific PCR was used to interrogate the 3′ region of the non-chimeric TNXB allele. Gene-specific sequencing identified a maternally inherited c.137_138delinsGA p.(Pro46Arg) variant, classified as a variant of uncertain significance, while P050-C1 MLPA demonstrated a paternally inherited deletion involving all tested CYP21A2 exons and TNXB exon 35. Broader TNXB analysis with P155 showed no additional exon-level copy-number abnormality. Relative read balance at selected TNXA/TNXB-informative positions supported the suspected rearrangement. Sequencing of the approximately 8.5 kb RCCX-spanning amplicon established a CH-1-compatible architecture and restricted the recombination breakpoint to a 371 bp interval. No additional potentially clinically relevant variant was identified within the sequenced region of the non-chimeric TNXB allele. This study provides detailed molecular resolution of a TNXA/TNXB CH-1 rearrangement and illustrates the value and limitations of complementary allele-specific analyses in phenotypically discordant CAH-X families.
- 28 October 2026
- Published by Bioscientifica in Journal of Molecular Endocrinology
- Vol. 77 (4)
Molecular resolution of a TNXA / TNXB CH-1 chimera and the non-chimeric TNXB allele in CAH-X
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency can co-occur with CAH-X syndrome, a connective tissue disorder caused by TNXB haploinsufficiency, resulting from TNXA/TNXB chimeric genes within the RCCX module. Here, we performed a family-based molecular investigation to define a complex RCCX rearrangement, confirm the TNXA/TNXB chimera architecture, and independently assess the non-chimeric TNXB allele in a phenotypically discordant father–daughter pair. The proband underwent targeted CYP21A2 variant screening, trio gene-specific CYP21A2 sequencing, and copy-number analysis by multiplex ligation-dependent probe amplification. TNXA/TNXB short-read data were examined at pseudogene-informative positions, and the rearranged allele was characterized by RCCX-spanning long-range PCR using CYP779F and Tena32F followed by sequencing. A separate 2,536 bp allele-specific PCR was used to interrogate the 3′ region of the non-chimeric TNXB allele. Gene-specific sequencing identified a maternally inherited c.137_138delinsGA p.(Pro46Arg) variant, classified as a variant of uncertain significance, while P050-C1 MLPA demonstrated a paternally inherited deletion involving all tested CYP21A2 exons and TNXB exon 35. Broader TNXB analysis with P155 showed no additional exon-level copy-number abnormality. Relative read balance at selected TNXA/TNXB-informative positions supported the suspected rearrangement. Sequencing of the approximately 8.5 kb RCCX-spanning amplicon established a CH-1-compatible architecture and restricted the recombination breakpoint to a 371 bp interval. No additional potentially clinically relevant variant was identified within the sequenced region of the non-chimeric TNXB allele. This study provides detailed molecular resolution of a TNXA/TNXB CH-1 rearrangement and illustrates the value and limitations of complementary allele-specific analyses in phenotypically discordant CAH-X families.
- 6 July 2026
- Published by S. Karger AG in Molecular Syndromology
- p. 1-7
Beyond the Spectrum: A Case Report of Phelan-McDermid Syndrome and the Atypical Teratoid/Rhabdoid Tumor Co-Occurrence
Introduction: Phelan-McDermid syndrome (PMS) is a neurodevelopmental disorder most often caused by terminal 22q13.3 deletions involving SHANK3. Although primarily associated with developmental delay, hypotonia, and autism spectrum disorder-like features, rare reports have described atypical teratoid/rhabdoid tumor (AT/RT) in PMS, suggesting a potential oncogenic link. Case Presentation: We report the clinical, molecular, and treatment features of a child with PMS and AT/RT and review previously published cases. The proband presented with global developmental delay, absent speech, hypotonia, joint laxity, and characteristic dysmorphic features. Chromosomal microarray revealed a ∼2.26 Mb terminal deletion at 22q13.32q13.33, encompassing 31 OMIM-listed genes including SHANK3. At 6 months of age, he was diagnosed with AT/RT and treated with multimodal chemotherapy and craniospinal radiotherapy, achieving remission. Literature review identified additional PMS patients with AT/RT, supporting a role for 22q instability in tumorigenesis. Conclusion: This case highlights a rare but clinically significant association between PMS and AT/RT. Awareness of this potential link and careful radiotherapy planning are warranted to optimize outcomes in affected individuals.
- 6 July 2026
- Published by S. Karger AG in Molecular Syndromology
- p. 1-7
Beyond the Spectrum: A Case Report of Phelan-McDermid Syndrome and the Atypical Teratoid/Rhabdoid Tumor Co-Occurrence
Introduction: Phelan-McDermid syndrome (PMS) is a neurodevelopmental disorder most often caused by terminal 22q13.3 deletions involving SHANK3. Although primarily associated with developmental delay, hypotonia, and autism spectrum disorder-like features, rare reports have described atypical teratoid/rhabdoid tumor (AT/RT) in PMS, suggesting a potential oncogenic link. Case Presentation: We report the clinical, molecular, and treatment features of a child with PMS and AT/RT and review previously published cases. The proband presented with global developmental delay, absent speech, hypotonia, joint laxity, and characteristic dysmorphic features. Chromosomal microarray revealed a ∼2.26 Mb terminal deletion at 22q13.32q13.33, encompassing 31 OMIM-listed genes including SHANK3. At 6 months of age, he was diagnosed with AT/RT and treated with multimodal chemotherapy and craniospinal radiotherapy, achieving remission. Literature review identified additional PMS patients with AT/RT, supporting a role for 22q instability in tumorigenesis. Conclusion: This case highlights a rare but clinically significant association between PMS and AT/RT. Awareness of this potential link and careful radiotherapy planning are warranted to optimize outcomes in affected individuals.
- Open Access
- 24 March 2026
- Published by Elsevier in JSES Reviews, Reports, and Techniques
- Vol. 6 (3) , 100730
Shoulder and genetics: what orthopedic surgeons need to know
- 24 March 2026
- Published by Elsevier in JSES Reviews, Reports, and Techniques
- Vol. 6 (3) , 100730
Open AccessShoulder and genetics: what orthopedic surgeons need to know
- Open Access
- 18 February 2026
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 34 (3) , 429-437
TMC6/8-associated epidermodysplasia verruciformis: germline variants and a complex structural alteration in a skin cancer predisposition syndrome
Hereditary epidermodysplasia verruciformis (EV) represents a paradigmatic inherited cutaneous syndrome linking viral susceptibility, immunity, and oncogenesis. Although biallelic variants in CIB1 , TMC6 , and TMC8 —encoding components of the keratinocyte-intrinsic antiviral complex—underlie most cases, the full mutational spectrum and its oncologic implications remain incompletely defined. We performed integrated genomic, histopathological, and longitudinal clinical analyses in six affected individuals from five unrelated families with confirmed hereditary EV. Comprehensive short-read sequencing, copy-number assessment, and optical genome mapping (OGM) were used to delineate the underlying genetic alterations, followed by long-range PCR and Sanger validation. Pathogenic or likely pathogenic germline variants affecting TMC6 or TMC8 were identified in all probands, providing molecular confirmation of disease. Four variants were novel, including splice-site, frameshift, and in-frame deletions. In one proband, OGM revealed a previously unrecognised complex del–inv–del structural variant spanning both TMC6 and TMC8 —the first reported example in hereditary EV. This rearrangement, confirmed at base-pair resolution, co-segregated with a synonymous TMC8 variant that served as a practical haplotypic marker for carrier testing. Clinically, all patients developed cutaneous squamous cell carcinoma (SCC), and several exhibited multifocal or aggressive disease, underscoring the deterministic malignant potential of hereditary EV. This study broadens the genetic and phenotypic spectrum of TMC6/TMC8 -associated EV, establishes complex structural rearrangement in the molecular etiology, and consolidates hereditary EV as a recessive cancer predisposition syndrome. Integrating high-resolution genome mapping into diagnostic workflows may uncover concealed allelic architecture in unresolved hereditary cancer syndromes.
- 18 February 2026
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 34 (3) , 429-437
Open AccessTMC6/8-associated epidermodysplasia verruciformis: germline variants and a complex structural alteration in a skin cancer predisposition syndrome
Hereditary epidermodysplasia verruciformis (EV) represents a paradigmatic inherited cutaneous syndrome linking viral susceptibility, immunity, and oncogenesis. Although biallelic variants in CIB1 , TMC6 , and TMC8 —encoding components of the keratinocyte-intrinsic antiviral complex—underlie most cases, the full mutational spectrum and its oncologic implications remain incompletely defined. We performed integrated genomic, histopathological, and longitudinal clinical analyses in six affected individuals from five unrelated families with confirmed hereditary EV. Comprehensive short-read sequencing, copy-number assessment, and optical genome mapping (OGM) were used to delineate the underlying genetic alterations, followed by long-range PCR and Sanger validation. Pathogenic or likely pathogenic germline variants affecting TMC6 or TMC8 were identified in all probands, providing molecular confirmation of disease. Four variants were novel, including splice-site, frameshift, and in-frame deletions. In one proband, OGM revealed a previously unrecognised complex del–inv–del structural variant spanning both TMC6 and TMC8 —the first reported example in hereditary EV. This rearrangement, confirmed at base-pair resolution, co-segregated with a synonymous TMC8 variant that served as a practical haplotypic marker for carrier testing. Clinically, all patients developed cutaneous squamous cell carcinoma (SCC), and several exhibited multifocal or aggressive disease, underscoring the deterministic malignant potential of hereditary EV. This study broadens the genetic and phenotypic spectrum of TMC6/TMC8 -associated EV, establishes complex structural rearrangement in the molecular etiology, and consolidates hereditary EV as a recessive cancer predisposition syndrome. Integrating high-resolution genome mapping into diagnostic workflows may uncover concealed allelic architecture in unresolved hereditary cancer syndromes.
- 30 September 2025
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 22 (3) , 380-386
A Cross-Sectional Study of CHEK2 Pathogenic Variants: Cancer Risk Spectrum and Clinical Insights
Aims: CHEK2 is a tumor suppressor gene involved in DNA damage response and a moderate-risk gene for breast cancer. However, its role in other malignancies remains unclear, and the clinical impact of biallelic CHEK2 mutations is not well understood. This study aims to expand the cancer risk spectrum of CHEK2, including rare tumors, and to provide insights into the phenotypes associated with biallelic mutations and Multiple Inherited Neoplasia Alleles Syndrome (MINAS). Materials and Methods: We analyzed 40 individuals from 34 families carrying CHEK2 mutations, identified via multigene panel testing for hereditary cancer syndromes. Next-generation sequencing was performed for the probands, and segregation analysis in affected relatives was conducted using Sanger sequencing. Clinical data, including cancer type, age at diagnosis, and family history, were obtained from medical records and clinical evaluations. Results: We identified 16 distinct CHEK2 mutations, with c.1427C>T (p.Thr476Met) being the most frequent. Breast cancer was the most common diagnosis (75%), followed by thyroid cancer and rare tumors, including pancreatic neuroendocrine and cerebellopontine angle tumors. Multiple primary cancers occurred in 15% of patients, and 10% had MINAS, harboring additional variants in genes like PTEN and BRCA2. Biallelic CHEK2 mutations were linked to severe phenotypes, including bilateral breast cancer and adolescent-onset polyposis. Conclusions: Our findings broaden the CHEK2-associated cancer spectrum, extending beyond breast cancer to include rare malignancies and complex presentations. The identification of biallelic mutations and MINAS underscores the need for comprehensive genetic testing and tailored surveillance. These insights are crucial for refining risk assessment, enhancing prevention, and improving clinical management for individuals harboring CHEK2 mutations.
- 30 September 2025
- Published by Ministry of Health, Ankara City Hospital in Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
- Vol. 22 (3) , 380-386
A Cross-Sectional Study of CHEK2 Pathogenic Variants: Cancer Risk Spectrum and Clinical Insights
Aims: CHEK2 is a tumor suppressor gene involved in DNA damage response and a moderate-risk gene for breast cancer. However, its role in other malignancies remains unclear, and the clinical impact of biallelic CHEK2 mutations is not well understood. This study aims to expand the cancer risk spectrum of CHEK2, including rare tumors, and to provide insights into the phenotypes associated with biallelic mutations and Multiple Inherited Neoplasia Alleles Syndrome (MINAS). Materials and Methods: We analyzed 40 individuals from 34 families carrying CHEK2 mutations, identified via multigene panel testing for hereditary cancer syndromes. Next-generation sequencing was performed for the probands, and segregation analysis in affected relatives was conducted using Sanger sequencing. Clinical data, including cancer type, age at diagnosis, and family history, were obtained from medical records and clinical evaluations. Results: We identified 16 distinct CHEK2 mutations, with c.1427C>T (p.Thr476Met) being the most frequent. Breast cancer was the most common diagnosis (75%), followed by thyroid cancer and rare tumors, including pancreatic neuroendocrine and cerebellopontine angle tumors. Multiple primary cancers occurred in 15% of patients, and 10% had MINAS, harboring additional variants in genes like PTEN and BRCA2. Biallelic CHEK2 mutations were linked to severe phenotypes, including bilateral breast cancer and adolescent-onset polyposis. Conclusions: Our findings broaden the CHEK2-associated cancer spectrum, extending beyond breast cancer to include rare malignancies and complex presentations. The identification of biallelic mutations and MINAS underscores the need for comprehensive genetic testing and tailored surveillance. These insights are crucial for refining risk assessment, enhancing prevention, and improving clinical management for individuals harboring CHEK2 mutations.
- 19 August 2025
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 85 (5) , e70046
Long‐Term Clinical Characterization of ENTPD1 ‐Related Spastic Paraplegia: A Novel Variant and Comprehensive Literature Review
Hereditary spastic paraplegia (HSP) represents a genetically heterogeneous group of neurodegenerative disorders characterized by progressive axonal degeneration of corticospinal upper motor neurons, leading to lower limb‐predominant spasticity and weakness. To date, 83 HSP subtypes have been reported, exhibiting either pure or complicated phenotypes. Among these, spastic paraplegia type 64 (SPG64) is an ultra‐rare form of complicated HSP caused by biallelic variants in ENTPD1 , which encodes an ectonucleotidase involved in purine metabolism. In this study, we report a proband presenting with neurodevelopmental regression, dysmorphic features and sensorimotor polyneuropathy, followed comprehensively for 6 years. Genetic analysis identified a novel homozygous NM_001776:c.1174C>T;p.Gln392Ter variant in ENTPD1 . A literature review reveals that 39 individuals with SPG64 have been reported, with clinical manifestations including cognitive decline (38/39), speech abnormalities (30/39) and brain malformations (16/31). However, aspects of the full phenotypic spectrum remain to be fully characterized. Notably, this case represents the first documented patient with long‐term follow‐up, providing valuable clinical insights into disease progression over time. Neuroimaging in the proband demonstrated the involvement of the posterior limb of the internal capsule and the ‘ear of the lynx’ sign, which was not previously reported in SPG64. Furthermore, the presence of sensorimotor polyneuropathy supports that neuropathy may be a previously unappreciated component of SPG64. Our findings highlight the importance of deep phenotyping and long‐term follow‐up in fully understanding the nature of this unique HSP subtype.
- 19 August 2025
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 85 (5) , e70046
Long‐Term Clinical Characterization of ENTPD1 ‐Related Spastic Paraplegia: A Novel Variant and Comprehensive Literature Review
Hereditary spastic paraplegia (HSP) represents a genetically heterogeneous group of neurodegenerative disorders characterized by progressive axonal degeneration of corticospinal upper motor neurons, leading to lower limb‐predominant spasticity and weakness. To date, 83 HSP subtypes have been reported, exhibiting either pure or complicated phenotypes. Among these, spastic paraplegia type 64 (SPG64) is an ultra‐rare form of complicated HSP caused by biallelic variants in ENTPD1 , which encodes an ectonucleotidase involved in purine metabolism. In this study, we report a proband presenting with neurodevelopmental regression, dysmorphic features and sensorimotor polyneuropathy, followed comprehensively for 6 years. Genetic analysis identified a novel homozygous NM_001776:c.1174C>T;p.Gln392Ter variant in ENTPD1 . A literature review reveals that 39 individuals with SPG64 have been reported, with clinical manifestations including cognitive decline (38/39), speech abnormalities (30/39) and brain malformations (16/31). However, aspects of the full phenotypic spectrum remain to be fully characterized. Notably, this case represents the first documented patient with long‐term follow‐up, providing valuable clinical insights into disease progression over time. Neuroimaging in the proband demonstrated the involvement of the posterior limb of the internal capsule and the ‘ear of the lynx’ sign, which was not previously reported in SPG64. Furthermore, the presence of sensorimotor polyneuropathy supports that neuropathy may be a previously unappreciated component of SPG64. Our findings highlight the importance of deep phenotyping and long‐term follow‐up in fully understanding the nature of this unique HSP subtype.
- Open Access
- 5 April 2023
- Published by Afyon Kocatepe University in Kocatepe Tıp Dergisi
- Vol. 24 (2) , 221-227
INVESTIGATION OF KNOWLEDGE, ATTITUDES, BEHAVIORS ABOUT OCCUPATIONAL HEALTH AND SAFETY OF MEDICAL SCHOOL STUDENTS AND RESEARCH ASSISTANT PHYSICIANS
AMAÇ: Çalışanların iş sağlığı ve güvenliği bilgi düzeyleri ve uygulamaları iş kazası riskinin azaltılmasında önemli bir yere sahiptir. Bu araştırmada tıp fakültesi son sınıf öğrencileri ve araştırma görevlisi doktorların iş sağlığı ve güvenliği konusundaki bilgi tutum ve davranışlarını incelemek amaçlanmıştır. GEREÇ VE YÖNTEM: Araştırmanın tasarımı kesitseldir. Araştırma 18 - 30 Eylül 2019 tarihleri arasında yapılmıştır. Araştırmanın evrenini tıp fakültesi son sınıf öğrencileri ve araştırma görevlisi doktorlar oluşturmaktadır. Veriler, katılımcıların sosyodemografik özellikleri ve iş sağlığı ve güvenliği bilgi, tutum ve davranışlarını belirmeye yönelik soruları içeren anket yoluyla gözlem altında ve online anket olarak toplanmıştır. BULGULAR: Katılımcıların %52.9’u iş kazası geçirmiş, geçirenlerin %70.6’sı (n=142) bildirim yapmıştır. Toksik tıbbi atıklarla riskli temas sonrası yapılması gerekenleri bilme durumları üç yıllık ve üstü araştırma görevlisi doktorlarda diğerlerine göre istatistiksel olarak daha yüksektir (p:0,015). Kan ve vücut sıvılarıyla temas sonrası yapılması gerekenleri bilme durumları asistanlığının ilk iki yılında olanlarda istatistiksel olarak düşüktür (p:0,001). SONUÇ: Katılımcıların %90.5'inin iş sağlığı ve güvenliği eğitimi aldığı halde toksik tıbbi atıklar, kan ve vücut sıvılarıyla temas gibi durumlar hakkında bilgilerinin yeterli düzeyde olmadığı belirlenmiştir. Teorik ve pratiğin harmanlandığı, beceri geliştirici ve önceliklendirilmiş konuların ağırlıklı olduğu eğitim revizyonu ile iş sağlığı ve güvenliği bilgi ve becerileri arttırılabilecektir.
- 5 April 2023
- Published by Afyon Kocatepe University in Kocatepe Tıp Dergisi
- Vol. 24 (2) , 221-227
Open AccessINVESTIGATION OF KNOWLEDGE, ATTITUDES, BEHAVIORS ABOUT OCCUPATIONAL HEALTH AND SAFETY OF MEDICAL SCHOOL STUDENTS AND RESEARCH ASSISTANT PHYSICIANS
AMAÇ: Çalışanların iş sağlığı ve güvenliği bilgi düzeyleri ve uygulamaları iş kazası riskinin azaltılmasında önemli bir yere sahiptir. Bu araştırmada tıp fakültesi son sınıf öğrencileri ve araştırma görevlisi doktorların iş sağlığı ve güvenliği konusundaki bilgi tutum ve davranışlarını incelemek amaçlanmıştır. GEREÇ VE YÖNTEM: Araştırmanın tasarımı kesitseldir. Araştırma 18 - 30 Eylül 2019 tarihleri arasında yapılmıştır. Araştırmanın evrenini tıp fakültesi son sınıf öğrencileri ve araştırma görevlisi doktorlar oluşturmaktadır. Veriler, katılımcıların sosyodemografik özellikleri ve iş sağlığı ve güvenliği bilgi, tutum ve davranışlarını belirmeye yönelik soruları içeren anket yoluyla gözlem altında ve online anket olarak toplanmıştır. BULGULAR: Katılımcıların %52.9’u iş kazası geçirmiş, geçirenlerin %70.6’sı (n=142) bildirim yapmıştır. Toksik tıbbi atıklarla riskli temas sonrası yapılması gerekenleri bilme durumları üç yıllık ve üstü araştırma görevlisi doktorlarda diğerlerine göre istatistiksel olarak daha yüksektir (p:0,015). Kan ve vücut sıvılarıyla temas sonrası yapılması gerekenleri bilme durumları asistanlığının ilk iki yılında olanlarda istatistiksel olarak düşüktür (p:0,001). SONUÇ: Katılımcıların %90.5'inin iş sağlığı ve güvenliği eğitimi aldığı halde toksik tıbbi atıklar, kan ve vücut sıvılarıyla temas gibi durumlar hakkında bilgilerinin yeterli düzeyde olmadığı belirlenmiştir. Teorik ve pratiğin harmanlandığı, beceri geliştirici ve önceliklendirilmiş konuların ağırlıklı olduğu eğitim revizyonu ile iş sağlığı ve güvenliği bilgi ve becerileri arttırılabilecektir.